Testosterone: Lessons Learned from TRAVERSE 2024

Androgen Society

Importance of a Multidisciplinary Care Team for the Treatment of Hem…

Allison Wheeler

Updates on the Pharmacokinetics of Efanesoctocog Alfa

Amy Shapiro

Pharmacokinetic Properties of Efanesoctocog Alfa

Steve Kitchen

Sequencing Treatments in Hemophilia A: When to Switch and Why

Cedric R. Hermans

Managing Hemophilia B With Inhibitors

XV Eurasian Hematology-Oncology Congress - EHOC 2024

A. Kupesiz

2023 Menopause Update

Yale School of Medicine

M. Minkin

ITP and Aging: Addressing the Unique Challenges

Platelet Disorder Support Association (PDSA)

C. Kessler

Weightloss in Menopause

Susan Brian

Different Uses of Efanesoctocog Alfa in Hemophilia A: Prophylaxis, P…

UCLA Health

D. Quon

Causes of Secondary ITP and Long-Term Risk of Other Diseases in ITP …

Platelet Disorder Support Association (PDSA)

D. Kuter

Type 1 Plasminogen Deficiency: Disease Overview and Evolving Managem…

Amy Shapiro

2024 Menopause Review

Yale School of Medicine

M. Minkin

Radiation for Hemostasis in Tumor-Related Bleeding

Emma DeLoughery

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Placental Adaptive Responses and Fetal Programming

INOVA

L. Myatt

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Yale School of Medicine

M. Minkin, E. Ratner

COGI 2024 Insights: Should Androgens Be Routinely Added to Menopause…

Alessandra Graziottin

Evaluation and Care of the Patient With Heavy Menstrual Bleeding

Scripps Health

A. Ma

ASH 2022 Health-Related QOL in Patients With Hemophilia A or B With …

ASH 2022 Conference Coverage

A. Shapiro